Paper Title
DEVELOPMENT AND IN-VITRO CHRATERIZATION OF CUBOSOMAL GEL FOR TOPICAL DELIVERY OF CELECOXIB FOR TREATMENT OF RHEUMATOID ARTHRITIS.
Article Identifiers
: Authors
Keywords
DEVELOPMENT AND IN-VITRO CHRATERIZATION OF CUBOSOMAL GEL FOR TOPICAL DELIVERY OF CELECOXIB FOR TREATMENT OF RHEUMATOID ARTHRITIS.
Abstract
Rheumatoid Arthritis (RA) is auto immune disorder causes inflammation in joints resulting pain & deformity in wrist, fingers and ankles. This disease arises in women more than men at any age. The manifestation of disease includes redness, inflammation.[1] Early diagnosis is important for improvement of symptoms but quite difficult to detect at early age as it depends upon gathering clinical information & history of patient. There is no permanent therapy to treat rheumatoid arthritis. For complete suppression of disease symptoms, rheumatologist need to observe activity constantly and correctly to adjust treatment schedule. From last 20 years, Disease modifying anti-rheumatoid drugs (DMARDs) has gained much attention because of their effectiveness and can efficiently reduce the activity of disease and considerably decrease the joint deformity. In current therapies DMARDS are rarely implemented for the treatment of disease. Several new biological DMARDS such as anti-CD20 antibody, TNF inhibitors etc. With increase in the number of drugs and treatment options available, the long term disease remission is not achieved in many cases and thus new therapeutic options are still needed.[2,3] The reason of occurring the rheumatoid arthritis is not clear till date, it is supposed that the disease occurs due to various genetic and environment factors. The disease causes the inflammation and thickening of the joint which occurs due to the immature system of the body directly attacking the joints. The disease may also result in low blood cell count, inflammation nearby the lungs and heart.
Downloads
How To Cite (APA)
Masood Iftikhar, Dr. Praveen Kumar, & Kritika Badola (August-2025). DEVELOPMENT AND IN-VITRO CHRATERIZATION OF CUBOSOMAL GEL FOR TOPICAL DELIVERY OF CELECOXIB FOR TREATMENT OF RHEUMATOID ARTHRITIS.. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 10(8), a448-a455. https://ijnrd.org/papers/IJNRD2508045.pdf
Issue
Volume 10 Issue 8, August-2025
Pages : a448-a455
Other Publication Details
Paper Reg. ID: IJNRD_308751
Published Paper Id: IJNRD2508045
Downloads: 000121995
Research Area: Science and Technology
Author Type: Indian Author
Country: -, -, India
Published Paper PDF: https://ijnrd.org/papers/IJNRD2508045.pdf
Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2508045
About Publisher
Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)
UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG
Copyright & License
© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition.
You are free to share, adapt, and redistribute the material, provided proper credit is given to the original author. 🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use.
Publication Timeline
Article Preview: View Full Paper
Call For Paper
IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the UGC CARE 2025 Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.
IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.
The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.
Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.
How to submit the paper?
By Our website
Click Here to Submit Paper Online
You can now publish your research in IJNRD. IJNRD is a Transparent Peer-Reviewed Open Access Journal Publication (Refereed Journal), aligning with New UGC and UGC CARE recommendations.
For more details, refer to the official notice: UGC Public Notice
Submit Paper Online
Important Dates for Current issue
Paper Submission Open For: November 2025
Current Issue: Volume 10 | Issue 11 | November 2025
Impact Factor: 8.76
Last Date for Paper Submission: Till 30-Nov-2025
Notification of Review Result: Within 1-2 Days after Submitting paper.
Publication of Paper: Within 01-02 Days after Submititng documents.
Frequency: Monthly (12 issue Annually).
Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.
Subject Category: Research Area
Call for Paper: More Details
Approval, Licenses and Indexing: More Details
